Article has no nextliveshere tags assigned

Article has no topics tags assigned

Article has no colleges tags assigned

Article has no audiences tags assigned

Article has no units tags assigned

Contacts are empty

These messages will display in edit mode only.

Local 12: Chemotherapy in recurrent ovarian cancer patients

UC researcher publishes New England Journal of Medicine study looking at outcomes

The five-year survival rate for ovarian cancer is only 36%, one of the worst cancer survival rates out there.

Finding the right treatments, however, is critical to changing that survival rate, according to Dr. Thomas Herzog, a professor at UC and gynecologic oncologist with UC Health. His team just released a study in the New England Journal of Medicine comparing those who just had chemotherapy with a recurrent cancer and those who had chemotherapy in addition to surgery when the cancer came back.

Watch the full segment. 

Featured photo courtesy of Unsplash.